Last update 23 Jan 2025

Sperogenix(Shanghai) Med Tech Co.,Ltd

Private Company|
2020|
Shanghai Shi, China

Overview

Tags

Nervous System Diseases
Congenital Disorders
Skin and Musculoskeletal Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
GR(Glucocorticoid receptor)1

Related

1
Drugs associated with Sperogenix(Shanghai) Med Tech Co.,Ltd
Vamorolone
Target
GR
Mechanism
GR agonists
Active Org.
Purna Pharmaceuticals NVPurna Pharmaceuticals NV [+5]
Originator Org.
ReveraGen BioPharma, Inc.ReveraGen BioPharma, Inc. [+1]
Active Indication
Muscular Dystrophy, Duchenne [+1]
Inactive Indication
Asthma [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Oct 2023
1
Clinical Trials associated with Sperogenix(Shanghai) Med Tech Co.,Ltd
CTR20232865
/ CompletedPhase 1
一项随机、交叉、开放标签，评价Vamorolone口服混悬液在中国健康成年男性受试者中单次给药后的药代动力学和安全性耐受性的研究
[Translation] A randomized, crossover, open-label study to evaluate the pharmacokinetics and safety and tolerability of vamorolone oral suspension after a single dose in healthy Chinese adult male subjects
100 Clinical Results associated with Sperogenix(Shanghai) Med Tech Co.,Ltd
Login to view more data
0 Patents (Medical) associated with Sperogenix(Shanghai) Med Tech Co.,Ltd
Login to view more data
100 Deals associated with Sperogenix(Shanghai) Med Tech Co.,Ltd
Login to view more data
100 Translational Medicine associated with Sperogenix(Shanghai) Med Tech Co.,Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Vamorolone
 ( GR )		Muscular Dystrophy, Duchenne
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free